4.7 Article

Antimalarial linear lipopeptides from a Panamanian strain of the marine cyanobacterium Lyngbya majuscula

期刊

JOURNAL OF NATURAL PRODUCTS
卷 70, 期 6, 页码 984-988

出版社

AMER CHEMICAL SOC
DOI: 10.1021/np0700772

关键词

-

资金

  1. FIC NIH HHS [U01 TW006634-01, U01 TW006634, 1-U01 TW006634-01] Funding Source: Medline
  2. NCI NIH HHS [U19 CA052955-160002, CA52955, U19 CA052955] Funding Source: Medline
  3. NIEHS NIH HHS [P30 ES00210, P30 ES000210] Funding Source: Medline
  4. NIGMS NIH HHS [R01 GM063554-01, R01 GM063554, GM63554] Funding Source: Medline
  5. NINDS NIH HHS [R01 NS053398] Funding Source: Medline

向作者/读者索取更多资源

As part of the Panama International Cooperative Biodiversity Groups (ICBG) project, two new (2, 4) and two known (1, 3) linear alkynoic lipopeptides have been isolated from a Panamanian strain of the marine cyanobacterium Lyngbya majuscula. Carmabin A (1), dragomabin (2), and dragonamide A (3) showed good antimalarial activity (IC50 4.3, 6.0, and 7.7 mu M, respectively), whereas the nonaromatic analogue, dragonamide B (4), was inactive. The planar structures of all four compounds were determined by NMR spectroscopy in combination with mass spectrometry, and their stereoconfigurations were established by chiral HPLC and by comparison of their optical rotations and NMR data with literature values.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据